The Rare Lung Diseases Consortium (RLDC) is a network of cooperating clinical centers and patient support organizations that are working with the National Institutes of Health (NIH) in a collaborative network whose novel structure is designed to accelerate clinical research and improve the delivery of medical care to individuals affected by rare lung diseases. Learn More>>>

Definitions and Explanations of Diseases:

Rare Interstitial Lung Disease:

Pediatric

• Children's Interstitial Lung Diseases (cHILD)

Adult

• Familial IPF
• Connective Tissue Interstitial Lung Disease (CTILD)

Lymphangioleiomyomatosis (LAM)

Pulmonary Alveolar Proteinosis (PAP)

Alpha-1 Antitrypsin Deficiency (Alpha-1)

Term Glossary

Links and Other Resources

Why your participation matters

Learn about Current Research Studies

Find/Contact support or advocacy groups in your area

Learn more about Rare Lung Diseases

Other Useful Resources

May 5, 2006 Press Release: NIH Launches Clinical Studies Nationwide to Investigate Rare Diseases

New! RDCRN Makes Contact Registry Available for Download to Facilitate Those Without Internet Access!

New Alpha-1 Education Days Announced! Details >>

Glossary | Frequently Asked Questions | Contact Web Master | Accessibility | Disclaimer | Site Map

Return to RDCRN Main Page